meclofenamic acid has been researched along with angiotensin ii, des-phe(8)- in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahima, RS; Kadowitz, PJ; Khosla, MC; Minkes, RK; Osei, SY; Weaver, JP | 1 |
| Baber, SR; Fokin, A; Greco, AJ; Kadowitz, PJ; Master, RG | 1 |
2 other study(ies) available for meclofenamic acid and angiotensin ii, des-phe(8)-
| Article | Year |
|---|---|
Differential responses to angiotensin-(1-7) in the feline mesenteric and hindquarters vascular beds.
Topics: Amino Acid Oxidoreductases; Angiotensin I; Angiotensin II; Angiotensin III; Animals; Arginine; Biphenyl Compounds; Cats; Hindlimb; Imidazoles; Losartan; Meclofenamic Acid; Mesenteric Artery, Superior; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peptide Fragments; Perfusion; Tetrazoles; Vascular Resistance; Vasoconstriction | 1993 |
Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Carotid Artery, External; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Enalaprilat; Male; Meclofenamic Acid; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptor, Bradykinin B2; Receptors, G-Protein-Coupled; Vasoconstrictor Agents; Vasodilator Agents | 2006 |